(2R,3S,4S,5S,6R)-2-[(2R,3R,4S,5S,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[[(2R,3R,4S,5S,6S)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Term ID

CHEBI:154026

Synonyms

alpha-D-manno-hexopyranosyl-(1->3)-alpha-D-manno-hexopyranosyl-(1->6)-[alpha-D-manno-hexopyranosyl-(1->3)]-alpha-D-manno-hexopyranose
Man(a1-3)Man(a1-6)[Man(a1-3)]a-Man
WURCS=2.0/1,4,3/[a1122h-1a_1-5]/1-1-1-1/a3-b1_a6-c1_c3-d1

Definition

References

GlyGen:G75411YK
GlyTouCan:G75411YK

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2R,3S,4S,5S,6R)-2-[(2R,3R,4S,5S,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[[(2R,3R,4S,5S,6S)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype where environments contain (2R,3S,4S,5S,6R)-2-[(2R,3R,4S,5S,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[[(2R,3R,4S,5S,6S)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype modified by environments containing (2R,3S,4S,5S,6R)-2-[(2R,3R,4S,5S,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[[(2R,3R,4S,5S,6S)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Phenotype affecting (2R,3S,4S,5S,6R)-2-[(2R,3R,4S,5S,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[[(2R,3R,4S,5S,6S)-3,5,6-trihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Human Disease Model